JPMorgan Chase & Co. is a leading global financial services firm that provides a wide range of financial solutions to consumers, businesses, and governments
The company offers investment banking, asset management, private banking, and wealth management services while also delivering a full suite of commercial banking products. With a strong emphasis on innovation and technology, JPMorgan Chase plays a pivotal role in the financial market, helping clients navigate complex financial landscapes through expert advice and tailored services. The firm is committed to maintaining its reputation for integrity and professionalism while actively contributing to economic development and community investment.
JPMorgan analyst maintains a Neutral rating on Academy Sports, raising the price target to $54, citing growth uncertainty amid macroeconomic challenges.
JP Morgan analysts question Dyne Therapeutics' strategy for DYNE-101 in DM1, highlighting regulatory uncertainty and investor concerns over data updates.
JP Morgan raised Syndax's price target to $41, citing strong early Revuforj sales and physician confidence in its use for acute leukemias and NPM1 AML.
JP Morgan launches VIX Short-Term Futures ETN to benefit from decreased market volatility, despite market expectations for volatility to continue or increase.
JP Morgan upgraded FCX to Overweight with price target of $52 from $48, citing sustained premium pricing and supply constraints, and potential protective measures for US copper imports.
Derek Chase, CEO of Los Angeles-based FLORA+BAST, contends that the unintended consequences of tariffs could push businesses toward more eco-conscious, locally sourced solutions.
J.P. Morgan, officially known today as JPMorgan Chase & Co. (NYSE:JPM), stands as one of the most influential financial institutions in the world. Its history spans over two centuries, weaving together tales of ambition, innovation, economic crises, and strategic mergers. From its origins as a modest merchant bank to
J.P. Morgan analyst John Ivankoe hosted Bloomin' Brands, CAVA Group and others at the Las Vegas forum. A major takeaway: focus on "doing fewer things better" with continued investments in customer and employee experiences. The analyst recommends adding fresh investments in BROS, SBUX, and CAVA, while maintaining cautious optimism on CMG and EAT.
JPMorgan upgrades Spire Inc. to Overweight, raises price forecast to $85. Analyst cites regulatory improvements in Missouri and positive factors for increased earnings and growth potential.
As of this morning, March 20, 2025, JPMorgan Chase & Co. (NYSE: JPM) is experiencing a modest uptick in its stock price. At 10:20:24 AM EDT, the stock is trading at $240.10, reflecting a gain of $0.99, or 0.41%, from its previous close of $239.11.
JPMorgan analyst sees Nvidia dominating in AI and potentially outgrowing data center spending with next-gen chips and potential AI factory investments.
Financial stocks are taking a tumble as the S&P 500 pushes into correction territory. Despite this, these stocks maintain solid fundamentals for the long-term.
Jamie Dimon, CEO of JPMorgan Chase & Co. (NYSE: JPM), expressed his views on the current economic landscape, highlighting concerns over geopolitical tensions and potential tariff impacts.
This comes ahead of the company’s investor day scheduled for March 25, where new CEO Andy Silvernail is set to field questions about the company’s strategies going forward.
Adobe Inc is showing strong AI-driven growth with $3.5 billion in annual recurring revenue and plans to double AI-first products, making it an attractive stock for investors.
Bank of America (BofA) said Nvidia is “deepening its competitive moat,” while JPMorgan noted that the company’s “aggressive roadmap” keeps it “1-2 steps ahead of its competitors.”
